FcγR requirements leading to successful immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FcγR requirements leading to successful immunotherapy

Published:2015-10-26 Issue:1 Volume:268 Page:104-122
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunol Rev

Author:

Dahal Lekh N.¹,Roghanian Ali¹,Beers Stephen A.¹,Cragg Mark S.¹

Affiliation:

1. Antibody and Vaccine Group; Cancer Sciences Unit; Faculty of Medicine; University of Southampton; General Hospital; Southampton UK

Funder

Leukaemia and Lymphoma Research

Roche

GlaxoSmithKline

Kay Kendall

Cancer Research UK

Biotechnology and Biological Sciences Research Council

Medical Research Council

Sparks

Institute for Life Sciences, Southampton

NIHR Southampton BRC

Bioinvent International

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imr.12342/fullpdf

Reference145 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Anti-CD20 monoclonal antibodies: historical and future perspectives;Lim;Haematologica,2010

3. Monoclonal antibody therapy of cancer;Adams;Nat Biotechnol,2005

4. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab;Li;Cancer Cell,2005

5. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets;Clynes;Nat Med,2000

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD177 is a novel IgG Fc receptor and CD177 genetic variants affect IgG-mediated function;Frontiers in Immunology;2024-07-26

2. CD177 is a novel IgG Fc receptor and CD177 genetic variants affect IgG-mediated function;2024-01-07

3. Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists;Frontiers in Immunology;2023-09-19

4. FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab;Frontiers in Immunology;2023-07-27

5. Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2;Cancers;2023-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3